Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas

被引:19
作者
Dietz, Steffen [1 ,2 ,3 ,4 ]
Harms, Alexander [3 ,5 ]
Endris, Volker [5 ]
Eichhorn, Florian [6 ]
Kriegsmann, Mark [5 ]
Longuespee, Remi [5 ]
Stenzinger, Albrecht [4 ,5 ]
Sueltmann, Holger [1 ,2 ,3 ,4 ]
Warth, Arne [3 ,5 ]
Kazdal, Daniel [3 ,5 ]
机构
[1] German Canc Res Ctr, Canc Genome Res Grp, Heidelberg, Germany
[2] Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[3] Heidelberg German Ctr Lung Res DZL, Translat Lung Res Ctr TLRC Heidelberg, Heidelberg, Germany
[4] German Canc Consortium DKTK, Heidelberg, Germany
[5] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany
[6] Univ Hosp Heidelberg, Dept Thorac Surg, Thoraxklin, Heidelberg, Germany
关键词
lung adenocarcinoma; driver gene mutation allele frequency; heterogeneity; histological growth pattern; PULMONARY ADENOCARCINOMA; CANCER; CLASSIFICATION; CHEMOTHERAPY; IMPACT;
D O I
10.1002/ijc.30881
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multiregional analysis provided first indications for morphological and molecular heterogeneity in lung adenocarcinomas (ADCs), but comprehensive morpho-molecular comparisons are still lacking. The purpose of our study was to investigate the spatial distribution of EGFR and KRAS alterations systematically throughout whole tumor cross-sections in correlation with the tumor cell content and the histopathological patterns. Central sections of 19 ADCs were subdivided into 467 segments of 5 mm x 5 mm. We determined the predominant histological growth pattern and the allele frequencies of driver gene mutations by digital PCR in every segment. We further quantified the absolute cell counts and proportions of tumor and nonneoplastic cells in all segments to normalize the mutant allele frequencies. Driver gene mutations could be detected in >99% of the tumor containing segments, with high levels of inter- and intratumor heterogeneity regarding the mutant allele frequency (range: 0.04-19.36). Different patterns for the distribution of the variant allele frequency within a tumor were recognizable. While some cases showed ubiquitously low or high levels, others revealed regions with focally elevated frequencies. Differences between KRAS and EGFR alterations were not significant. The great majority of the analyzed tumor sections (16/19) exhibited two or more morphological growth patterns. Mutant allele frequencies were significantly higher in segments with a predominant solid pattern compared to all other histologies (p < 0.01). Our data indicate that driver gene mutations are present with high levels of inter- and intratumor heterogeneity throughout the whole tumor, with a correlation between the allele frequencies and histological growth patterns.
引用
收藏
页码:1841 / 1848
页数:8
相关论文
共 26 条
[1]  
[Anonymous], 2017, SEER CANC STAT REV 1
[2]   Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer [J].
Bai, Hua ;
Wang, Zhijie ;
Wang, Yuyan ;
Zhuo, Minglei ;
Zhou, Qinghua ;
Duan, Jianchun ;
Yang, Lu ;
Wu, Meina ;
An, Tongtong ;
Zhao, Jun ;
Wang, Jie .
PLOS ONE, 2013, 8 (02)
[3]   Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas [J].
Campbell, Joshua D. ;
Alexandrov, Anton ;
Kim, Jaegil ;
Wala, Jeremiah ;
Berger, Alice H. ;
Pedamallu, Chandra Sekhar ;
Shukla, Sachet A. ;
Guo, Guangwu ;
Brooks, Angela N. ;
Murray, Bradley A. ;
Imielinski, Marcin ;
Hu, Xin ;
Ling, Shiyun ;
Akbani, Rehan ;
Rosenberg, Mara ;
Cibulskis, Carrie ;
Ramachandran, Aruna ;
Collisson, Eric A. ;
Kwiatkowski, David J. ;
Lawrence, Michael S. ;
Weinstein, John N. ;
Verhaak, Roel G. W. ;
Wu, Catherine J. ;
Hammerman, Peter S. ;
Cherniack, Andrew D. ;
Getz, Gad ;
Artyomov, Maxim N. ;
Schreiber, Robert ;
Govindan, Ramaswamy ;
Meyerson, Matthew .
NATURE GENETICS, 2016, 48 (06) :607-+
[4]   Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma-Rationale for Comprehensive Mutation Profiling [J].
Chaft, Jamie E. ;
Arcila, Maria E. ;
Paik, Paul K. ;
Lau, Christopher ;
Riely, Gregory J. ;
Pietanza, M. Catherine ;
Zakowski, Maureen F. ;
Rusch, Valerie ;
Sima, Camelia S. ;
Ladanyi, Marc ;
Kris, Mark G. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (02) :485-491
[5]   Comprehensive molecular profiling of lung adenocarcinoma [J].
Collisson, Eric A. ;
Campbell, Joshua D. ;
Brooks, Angela N. ;
Berger, Alice H. ;
Lee, William ;
Chmielecki, Juliann ;
Beer, David G. ;
Cope, Leslie ;
Creighton, Chad J. ;
Danilova, Ludmila ;
Ding, Li ;
Getz, Gad ;
Hammerman, Peter S. ;
Hayes, D. Neil ;
Hernandez, Bryan ;
Herman, James G. ;
Heymach, John V. ;
Jurisica, Igor ;
Kucherlapati, Raju ;
Kwiatkowski, David ;
Ladanyi, Marc ;
Robertson, Gordon ;
Schultz, Nikolaus ;
Shen, Ronglai ;
Sinha, Rileen ;
Sougnez, Carrie ;
Tsao, Ming-Sound ;
Travis, William D. ;
Weinstein, John N. ;
Wigle, Dennis A. ;
Wilkerson, Matthew D. ;
Chu, Andy ;
Cherniack, Andrew D. ;
Hadjipanayis, Angela ;
Rosenberg, Mara ;
Weisenberger, Daniel J. ;
Laird, Peter W. ;
Radenbaugh, Amie ;
Ma, Singer ;
Stuart, Joshua M. ;
Byers, Lauren Averett ;
Baylin, Stephen B. ;
Govindan, Ramaswamy ;
Meyerson, Matthew ;
Rosenberg, Mara ;
Gabriel, Stacey B. ;
Cibulskis, Kristian ;
Sougnez, Carrie ;
Kim, Jaegil ;
Stewart, Chip .
NATURE, 2014, 511 (7511) :543-550
[6]   Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients [J].
Dietz, Steffen ;
Schirmer, Uwe ;
Merce, Clementine ;
von Bubnoff, Nikolas ;
Dahl, Edgar ;
Meister, Michael ;
Muley, Thomas ;
Thomas, Michael ;
Sueltmann, Holger .
PLOS ONE, 2016, 11 (08)
[7]   Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach Feasibility, Costs, and Performance Compared with Conventional Sequencing [J].
Endris, Volker ;
Penzel, Roland ;
Warth, Arne ;
Muckenhuber, Alexander ;
Schirmacher, Peter ;
Stenzinger, Albrecht ;
Weichert, Wilko .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06) :765-775
[8]   Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition [J].
Hata, Aaron N. ;
Niederst, Matthew J. ;
Archibald, Hannah L. ;
Gomez-Caraballo, Maria ;
Siddiqui, Faria M. ;
Mulvey, Hillary E. ;
Maruvka, Yosef E. ;
Ji, Fei ;
Bhang, Hyo-eun C. ;
Radhakrishna, Viveksagar Krishnamurthy ;
Siravegna, Giulia ;
Hu, Haichuan ;
Raoof, Sana ;
Lockerman, Elizabeth ;
Kalsy, Anuj ;
Lee, Dana ;
Keating, Celina L. ;
Ruddy, David A. ;
Damon, Leah J. ;
Crystal, Adam S. ;
Costa, Carlotta ;
Piotrowska, Zofia ;
Bardelli, Alberto ;
Iafrate, Anthony J. ;
Sadreyev, Ruslan I. ;
Stegmeier, Frank ;
Getz, Gad ;
Sequist, Lecia V. ;
Faber, Anthony C. ;
Engelman, Jeffrey A. .
NATURE MEDICINE, 2016, 22 (03) :262-269
[9]   Tracking the Evolution of Non-Small-Cell Lung Cancer [J].
Jamal-Hanjani, M. ;
Wilson, G. A. ;
McGranahan, N. ;
Birkbak, N. J. ;
Watkins, T. B. K. ;
Veeriah, S. ;
Shafi, S. ;
Johnson, D. H. ;
Mitter, R. ;
Rosenthal, R. ;
Salm, M. ;
Horswell, S. ;
Escudero, M. ;
Matthews, N. ;
Rowan, A. ;
Chambers, T. ;
Moore, D. A. ;
Turajlic, S. ;
Xu, H. ;
Lee, S. -M. ;
Forster, M. D. ;
Ahmad, T. ;
Hiley, C. T. ;
Abbosh, C. ;
Falzon, M. ;
Borg, E. ;
Marafioti, T. ;
Lawrence, D. ;
Hayward, M. ;
Kolvekar, S. ;
Panagiotopoulos, N. ;
Janes, S. M. ;
Thakrar, R. ;
Ahmed, A. ;
Blackhall, F. ;
Summers, Y. ;
Shah, R. ;
Joseph, L. ;
Quinn, A. M. ;
Crosbie, P. A. ;
Naidu, B. ;
Middleton, G. ;
Langman, G. ;
Trotter, S. ;
Nicolson, M. ;
Remmen, H. ;
Kerr, K. ;
Chetty, M. ;
Gomersall, L. ;
Fennell, D. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (22) :2109-2121
[10]   Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer [J].
Kazdal, Daniel ;
Harms, Alexander ;
Endris, Volker ;
Penzel, Roland ;
Kriegsmann, Mark ;
Eichhorn, Florian ;
Muley, Thomas ;
Stenzinger, Albrecht ;
Pfarr, Nicole ;
Weichert, Wilko ;
Warth, Arne .
BRITISH JOURNAL OF CANCER, 2017, 117 (02) :220-226